To forwardly support that the activation of Akt and glycolysis was implicated in the acquired resistance, we examined whether the inhibition of Akt or glycolysis could re-sensitize resistant melanoma cells to Vemurafenib treatment. This evidence concerns the gene AKT1 and melanoma.